Trichomonas vaginalis 1

Product list
The WHO has estimated that 160 million cases of infection are acquired annually worldwide. Trichomonas vaginalis is an anaerobic, flagellated protozoan parasite and the causative agent of trichomoniasis. It is the most common pathogenic protozoan infection of humans in industrialized countries. Usually treatment consists of metronidazole and tinidazole.
Show More Close

Inquiry

Recombinant Anti-T. vaginalis 1 Antibody (V3S-1022-YC5352) (CAT#: V3S-1022-YC5352)

Target: T. vaginalis 1

Host Species: Mouse

Target Species: Protozoan,

Application: IA,

For research use only, not directly for clinical use.


banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry